Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Don't Ask Rambi -- Ignore unavailable to you. Want to Upgrade?

To: Ilaine who wrote (46660)	2/11/2000 5:27:00 PM
From: Jacques Chitte	Read Replies (2) \| Respond to of 71178

There's a company called Medtronic that markets an implantable, programmable delivery device (pump) for intrathecal administration of CNS actives. I found a reference that describes the experimental use of conopeptides for mitigating neuropathic pain. hosppract.com But these conotoxins are undeveloped as clinical meds. There are alternatives - opiates (morphine), GABA agents (baclofen, gabapentin) and others (clonidine). If I had chronic neuropathic pain, I'd consider these.